Abstract:Protein inverse folding-that is, predicting an amino acid sequence that will fold into the desired 3D structure-is an important problem for structure-based protein design. Machine learning based methods for inverse folding typically use recovery of the original sequence as the optimization objective. However, inverse folding is a one-to-many problem where several sequences can fold to the same structure. Moreover, for many practical applications, it is often desirable to have multiple, diverse sequences that fold into the target structure since it allows for more candidate sequences for downstream optimizations. Here, we demonstrate that although recent inverse folding methods show increased sequence recovery, their "foldable diversity"-i.e. their ability to generate multiple non-similar sequences that fold into the structures consistent with the target-does not increase. To address this, we present RL-DIF, a categorical diffusion model for inverse folding that is pre-trained on sequence recovery and tuned via reinforcement learning on structural consistency. We find that RL-DIF achieves comparable sequence recovery and structural consistency to benchmark models but shows greater foldable diversity: experiments show RL-DIF can achieve an foldable diversity of 29% on CATH 4.2, compared to 23% from models trained on the same dataset. The PyTorch model weights and sampling code are available on GitHub.
Abstract:We envision 'AI scientists' as systems capable of skeptical learning and reasoning that empower biomedical research through collaborative agents that integrate machine learning tools with experimental platforms. Rather than taking humans out of the discovery process, biomedical AI agents combine human creativity and expertise with AI's ability to analyze large datasets, navigate hypothesis spaces, and execute repetitive tasks. AI agents are proficient in a variety of tasks, including self-assessment and planning of discovery workflows. These agents use large language models and generative models to feature structured memory for continual learning and use machine learning tools to incorporate scientific knowledge, biological principles, and theories. AI agents can impact areas ranging from hybrid cell simulation, programmable control of phenotypes, and the design of cellular circuits to the development of new therapies.
Abstract:Graph-centric artificial intelligence (graph AI) has achieved remarkable success in modeling interacting systems prevalent in nature, from dynamical systems in biology to particle physics. The increasing heterogeneity of data calls for graph neural architectures that can combine multiple inductive biases. However, combining data from various sources is challenging because appropriate inductive bias may vary by data modality. Multimodal learning methods fuse multiple data modalities while leveraging cross-modal dependencies to address this challenge. Here, we survey 140 studies in graph-centric AI and realize that diverse data types are increasingly brought together using graphs and fed into sophisticated multimodal models. These models stratify into image-, language-, and knowledge-grounded multimodal learning. We put forward an algorithmic blueprint for multimodal graph learning based on this categorization. The blueprint serves as a way to group state-of-the-art architectures that treat multimodal data by choosing appropriately four different components. This effort can pave the way for standardizing the design of sophisticated multimodal architectures for highly complex real-world problems.